Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Injectable Methylprednisolone Sodium Succinate in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome Under the New Coronavirus (SARS-CoV2): a Phase IIb, Randomized, Double-blind, Placebo-controlled, Clinical Trial.

NCT04343729 is registered in ClinicalTrials.gov with Fundação de Medicina Tropical Dr. Heitor Vieira Dourado as lead sponsor.

NCT NCT04343729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04343729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Injectable Methylprednisolone Sodium Succinate in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome Under the New Coronavirus (SARS-CoV2): a Phase IIb, Randomized, Double-blind, Placebo-controlled, Clinical Trial.
Lead sponsor
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Phase
Phase 2
Overall status
Completed
Start date
April 18, 2020
Completion date
October 20, 2020
Enrollment
416 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov infection, severe acute respiratory syndrome (sars) pneumonia